erythrosine has been researched along with Coronary Disease in 27 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The dose-response RR of CHD for an increase in heme iron intake of 1 mg/day was 1." | 6.50 | Is heme iron intake associated with risk of coronary heart disease? A meta-analysis of prospective studies. ( Dong, X; Li, B; Tang, YH; Xu, JJ; Yang, W; Zeng, Y; Zhang, XQ; Zhou, JL, 2014) |
| " The dose-response RR of CHD for an increase in heme iron intake of 1 mg/day was 1." | 2.50 | Is heme iron intake associated with risk of coronary heart disease? A meta-analysis of prospective studies. ( Dong, X; Li, B; Tang, YH; Xu, JJ; Yang, W; Zeng, Y; Zhang, XQ; Zhou, JL, 2014) |
| "Postoperative treatment of ventricular arrhythmia with MSC is a promising procedure and merits further clinical and experimental investigation." | 1.26 | Antiarrhythmic effect of Mercurascan in patients after surgical treatment of ischaemic heart disease. ( Janota, M; Málek, P; Vrána, M; Vránová, Z, 1976) |
| "The distance between perfusion and anoxia was measured on the border of an experimental ischemic area in the rabbit heart." | 1.26 | Visualization of the distance between perfusion and anoxia along an ischemic border. ( Barlow, C; Harden, W; Harken, AH; Simson, MB, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (92.59) | 18.7374 |
| 1990's | 1 (3.70) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (3.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, W | 1 |
| Li, B | 1 |
| Dong, X | 1 |
| Zhang, XQ | 1 |
| Zeng, Y | 1 |
| Zhou, JL | 1 |
| Tang, YH | 1 |
| Xu, JJ | 1 |
| NOWOSLAWSKI, A | 1 |
| Málek, P | 7 |
| Vavrejn, B | 2 |
| Ratuský, J | 2 |
| Kronrád, L | 2 |
| Kolc, J | 5 |
| Burstin, J | 1 |
| Pressa, C | 1 |
| Mateu, JM | 1 |
| Mawson, JB | 2 |
| Gavin, JB | 3 |
| Seelye, RN | 1 |
| Herdson, PB | 2 |
| Camilleri, JP | 1 |
| Nlom, MO | 1 |
| Joseph, D | 1 |
| Michel, JB | 1 |
| Barres, D | 1 |
| Mignot, J | 1 |
| Humphrey, SM | 1 |
| Thomson, RW | 1 |
| Arnold, WL | 1 |
| DeWall, RA | 1 |
| Kezdi, P | 1 |
| Zwart, HH | 1 |
| Málek, I | 1 |
| Mrhová, O | 2 |
| Urbanová, D | 1 |
| Vránová, Z | 2 |
| Janota, M | 1 |
| Vrána, M | 3 |
| Simson, MB | 2 |
| Harden, WR | 1 |
| Barlow, CH | 1 |
| Harken, AH | 2 |
| Harden, W | 1 |
| Barlow, C | 1 |
| Ekeström, S | 1 |
| Lund, F | 1 |
| Brodan, V | 1 |
| Táborský, J | 1 |
| Hejnal, J | 1 |
| Andĕl, M | 1 |
| Kucerová, V | 1 |
| Blombäck, B | 1 |
| Banerjee, D | 1 |
| Carlsson, K | 1 |
| Hamsten, A | 1 |
| Hessel, B | 1 |
| Procyk, R | 1 |
| Silveira, A | 1 |
| Zacharski, L | 1 |
| Rosolowsky, M | 1 |
| Weiss, HR | 1 |
| McDonagh, PF | 1 |
| Roberts, DJ | 1 |
| Taira, Y | 1 |
| Kanaide, H | 1 |
| Nakamura, M | 1 |
| Batrachenko, IP | 1 |
| Rudakova, IS | 1 |
| Chernukh, AM | 1 |
| Clarke, DB | 1 |
| Neligan, MC | 1 |
| Blazek, Z | 1 |
| Cherry, G | 1 |
| Myers, MB | 1 |
| Armellini, C | 1 |
| Mersheimer, WL | 1 |
| Burman, SO | 1 |
| Magovern, GJ | 1 |
1 review available for erythrosine and Coronary Disease
| Article | Year |
|---|---|
Is heme iron intake associated with risk of coronary heart disease? A meta-analysis of prospective studies.
Topics: Adult; Aged; Coronary Disease; Female; Fluoresceins; Heme; Humans; Hydroxyl Radical; Iron; Lipoprote | 2014 |
26 other studies available for erythrosine and Coronary Disease
| Article | Year |
|---|---|
[IMMUNOHISTOCHEMICAL STUDIES ON THE PRESENCE AND DISTRIBUTION OF SERUM PROTEINS IN FOCI OF EARLY ARTERIOSCLEROTIC CHANGES IN THE CORONARY ARTERIES].
Topics: Blood Proteins; Coronary Disease; Coronary Vessels; Fluoresceins; Fluorescent Antibody Technique; Hu | 1963 |
[Velocity of the selective accumulation of Mercurascan 203 in injured muscle and in the ischemic myocardium].
Topics: Animals; Coronary Disease; Dogs; Fluoresceins; Mercury Isotopes; Muscles; Myocardium; Radionuclide I | 1967 |
Cardioplegia with fluorescein for visualization of coronary arteries.
Topics: Animals; Coronary Disease; Coronary Vessels; Dogs; Fluoresceins; Heart Arrest, Induced | 1981 |
A method for the gross and microscopic investigation of vascular reperfusion in ischemic myocardium.
Topics: Animals; Coronary Disease; Coronary Vessels; Dextrans; Fluorescein-5-isothiocyanate; Fluoresceins; F | 1982 |
A comparison of the effects of ischemia and of selective occlusion of capillaries, pre-capillaries and terminal arterioles on coronary reperfusion.
Topics: Animals; Arterioles; Capillaries; Constriction, Pathologic; Coronary Circulation; Coronary Disease; | 1982 |
Capillary perfusion patterns in reperfused ischemic subendocardial myocardium: experimental study using fluorescent dextran.
Topics: Acute Disease; Animals; Capillary Permeability; Coronary Circulation; Coronary Disease; Dextrans; En | 1983 |
The effect of an isovolumic left ventricle on the coronary vascular competence during reflow after global ischemia in the rat heart.
Topics: Animals; Coronary Circulation; Coronary Disease; Fluoresceins; Heart Ventricles; Male; Myocardium; R | 1981 |
The effect of allopurinol on the degree of early myocardial ischemia.
Topics: Allopurinol; Animals; Cardiac Output; Coronary Angiography; Coronary Disease; Dogs; Female; Fluoresc | 1980 |
Protective effect of Mercurascan after coronary artery ligation in the dog.
Topics: Animals; Coronary Disease; Coronary Vessels; Creatine Kinase; Disease Models, Animal; Dogs; Electroc | 1980 |
Antiarrhythmic effect of Mercurascan in patients after surgical treatment of ischaemic heart disease.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Artery Bypass; Coronary Disease; Drug Evaluat | 1976 |
Epicardial ischemia as delineated with epicardial S-T segment mapping andnicotinamide adenine dinucleotide (NADH) fluorescence photography.
Topics: Animals; Coronary Disease; Electrocardiography; Fluoresceins; Fluorescence; Myocardium; NAD; Photogr | 1979 |
Visualization of the distance between perfusion and anoxia along an ischemic border.
Topics: Animals; Coronary Disease; Fluoresceins; Fluorescence; Freezing; Hypoxia; Male; Mitochondria, Heart; | 1979 |
Intraoperative fluorescein angiography in reconstructive surgery of coronary and renal artery disease.
Topics: Adolescent; Child; Coronary Artery Bypass; Coronary Disease; Fluorescein Angiography; Fluoresceins; | 1977 |
[The effect of mercurascan on some of the metabolic parameters of myocardial ischaemia in the early phases after heart transplantation in the dog (author's transl)].
Topics: Animals; Coronary Disease; Dogs; Fluoresceins; Heart Transplantation; Lactates; Myocardium; Organome | 1979 |
[Complex effect of mercurascan on ischaemia-induced myocardial injury].
Topics: Animals; Coronary Disease; Dogs; Fluoresceins; Mercury; Myocardium; Organomercury Compounds | 1975 |
Native fibrin gel networks and factors influencing their formation in health and disease.
Topics: Adult; Afibrinogenemia; Blood Coagulation; Coronary Disease; Factor XIII; Fibrin; Fibrinogen; Fluore | 1990 |
Quantitative morphometric determination of arteriolar and capillary perfusion within ischemic rabbit left ventricle.
Topics: Animals; Arterioles; Capillaries; Collateral Circulation; Coronary Circulation; Coronary Disease; De | 1986 |
Prevention of transcoronary macromolecular leakage after ischemia-reperfusion by the calcium entry blocker nisoldipine. Direct observations in isolated rat hearts.
Topics: Animals; Capillaries; Coronary Circulation; Coronary Disease; Coronary Vessels; Extravasation of Dia | 1986 |
Coronary venous perfusion of the ischemic myocardium during acute coronary artery occlusion in isolated rat hearts.
Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Benzothiazoles; Coronary Disease; Coronary Vess | 1985 |
[Diagnostic possibility of fluorescein angiography of the ocular fundus in retinal vascular disorders].
Topics: Adult; Aged; Angiography; Coronary Disease; Eye Diseases; Female; Fluoresceins; Humans; Hypertension | 1969 |
Changes in the state of the microvascular bed and in the extent of transcapillary exchange by preparations with P-vitamin activity.
Topics: Amantadine; Animals; Capillaries; Capillary Permeability; Coronary Disease; Coumarins; Flavonoids; F | 1969 |
Multiple prosthetic vascular implants into the acutely ischaemic myocardium.
Topics: Animals; Blood Vessel Prosthesis; Coronary Disease; Coronary Vessels; Dogs; Fluoresceins; Heart Vent | 1970 |
Effect of mercury derivatives of fluorescein on the fibrillation threshold in experimental myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Dogs; Fluoresceins; Mercury Isotopes; Myocardial In | 1971 |
The use of vital dyes to predict survival after experimental coronary artery ligation.
Topics: Angiocardiography; Animals; Blood Circulation; Collateral Circulation; Coronary Disease; Coronary Ve | 1968 |
The use of fluorescein for determining the site for internal mammary artery implantation.
Topics: Animals; Coronary Disease; Coronary Vessels; Dogs; Fluoresceins; Methods; Motion Pictures; Thoracic | 1968 |
[Further advances in the topical diagnosis of ischemic myocardial lesions in vivo].
Topics: Animals; Coronary Disease; Dogs; Fluoresceins; Mercury; Radionuclide Imaging | 1966 |